High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemiaDaisuke Tomizawa, Souichi Adachi, Daiichiro Hasegawa et al.|Leukemia|2023Cited by 8
High <i>IL2RA</i>/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factorTakahiro Aoki, Daisuke Tomizawa, Norio Shiba et al.|Pediatric Blood & Cancer|2023Cited by 7
Metabolic Reprogramming By PRDM16 Drives Cytarabine Resistance in Acute Myeloid LeukemiaJunji Ikeda, Hideaki Nakajima, Hiroyoshi Kunimoto et al.|Blood|2023Cited by 1